Literature DB >> 2589876

Ciprofloxacin in neonatal Enterobacter cloacae septicaemia.

M J Bannon1, P R Stutchfield, A M Weindling, V Damjanovic.   

Abstract

Multiresistant Enterobacter cloacae infection in six premature infants was eradicated with intravenous ciprofloxacin (10 mg/kg/day). Bacterial resistance did not develop. Adequate plasma ciprofloxacin concentrations were achieved in all treated patients. No clinical evidence of side effects was observed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2589876      PMCID： PMC1590107          DOI： 10.1136/adc.64.10_spec_no.1388

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges.

Authors:  J B McClain; J Rhoads; G Krol
Journal:  J Antimicrob Chemother       Date:  1988-06       Impact factor: 5.790

2.  Successful treatment of Pseudomonas ventriculitis with ciprofloxacin.

Authors:  D Isaacs; M P Slack; A R Wilkinson; A W Westwood
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

3.  Resistance to ciprofloxacin.

Authors:  S T Chapman; D C Speller; D S Reeves
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

4.  Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.

Authors:  N Modi; V Damjanovic; R W Cooke
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

5.  Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.

Authors:  B E Scully; H C Neu; M F Parry; W Mandell
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321
  5 in total
  9 in total

Review 1.  Fluoroquinolones in paediatrics.

Authors:  D Gendrel; F Moulin
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Ciprofloxacin in typhoid fever.

Authors:  A Bavdekar; M Chaudhari; S Bhave; A Pandit
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

Review 3.  Ventriculitis caused by Klebsiella pneumoniae successfully treated with pefloxacin in a neonate.

Authors:  N Linder; R Dagan; J Kuint; N Keler; G Keren; B Reichman
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

Review 4.  Use of quinolones in pediatrics.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 5.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

6.  Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children.

Authors:  H Peltola; M Väärälä; O V Renkonen; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 7.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 8.  Ciprofloxacin safety in paediatrics: a systematic review.

Authors:  Abiodun Adefurin; Helen Sammons; Evelyne Jacqz-Aigrain; Imti Choonara
Journal:  Arch Dis Child       Date:  2011-07-23       Impact factor: 3.791

Review 9.  Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates.

Authors:  Nusrat Shafiq; Samir Malhotra; Vikas Gautam; Harpreet Kaur; Pravin Kumar; Sourabh Dutta; Pallab Ray; Nilima A Kshirsagar
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.